col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Springer-Verlag: Pharmacological Reports
  original article Date Title Authors   All Authors
1 [GO] 2021―Jul―06 The application of in silico experimental model in the assessment of ciprofloxacin and levofloxacin interaction with main SARS-CoV-2 targets: S-, E- and TMPRSS2 proteins, RNA-dependent RNA polymerase and papain-like protease (PLpro)-preliminary molecular docking analysis Krzysztof Marciniec, Artur Beberok, Stanisław Boryczka, Dorota Wrześniok
2 [GO] 2021―Jun―27 Understanding the role of ACE-2 receptor in pathogenesis of COVID-19 disease: a potential approach for therapeutic intervention Ekta Shirbhate, Jaiprakash Pandey, Vijay K. Patel, Mehnaz Kamal, Talha Jawaid, Bapi Gorain, et al. (+2)
3 [GO] 2021―Jun―24 Novel adenosine derivatives against SARS-CoV-2 RNA-dependent RNA polymerase: an in silico perspective Amr Sonousi, Hanan A. Mahran, Ibrahim M. Ibrahim, Mohamed N. Ibrahim, Abdo A. Elfiky, Wael M. Elshemey
4 [GO] 2021―Jun―04 Use of glucocorticoids and azithromycin in the therapy of COVID-19 Miguel de Lemos Neto, Rafael Costa Vieira Alexandre, Rafaela Oliveira Gallart Morra, Juliana Aparecida Souza da Paz, Shana Priscila Coutinho Barroso, Angela Castro Resende, et al. (+2)
5 [GO] 2021―May―10 Rifampicin and Letermovir as potential repurposed drug candidate for COVID-19 treatment: insights from an in-silico study Yamini Pathak, Amaresh Mishra, Gourav Choudhir, Anuj Kumar, Vishwas Tripathi
6 [GO] 2021―Apr―21 Role of pirfenidone in TGF-β pathways and other inflammatory pathways in acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection: a theoretical perspective Seyed Hootan Hamidi, Sandhya Kadamboor Veethil, Seyedeh Harir Hamidi
7 [GO] 2021―Apr―11 Proton pump inhibitor on susceptibility to COVID-19 and its severity: a systematic review and meta-analysis Raymond Pranata, Ian Huang, Sherly Lawrensia, Joshua Henrina, Michael Anthonius Lim, Antonia Anna Lukito, et al. (+2)
8 [GO] 2021―Mar―29 The association between the use of ivermectin and mortality in patients with COVID-19: a meta-analysis Chia Siang Kow, Hamid A. Merchant, Zia Ul Mustafa, Syed Shahzad Hasan
9 [GO] 2021―Mar―05 Perspectives on glucocorticoid treatment for COVID-19: a systematic review Leonardo P. Cordeiro, Eduarda O. N. N. Linhares, Fernanda G. O. Nogueira, Daniel Moreira-Silva, Daniel J. M. Medeiros-Lima
10 [GO] 2021―Feb―24 Evaluation of effects of chronic nasal steroid use on rhinological symptoms of COVID-19 with SNOT-22 questionnaire Akif İşlek, Mustafa Koray Balcı
11 [GO] 2021―Feb―20 In-hospital use of statins is associated with a reduced risk of mortality in coronavirus-2019 (COVID-19): systematic review and meta-analysis Hikmat Permana, Ian Huang, Aga Purwiga, Nuraini Yasmin Kusumawardhani, Teddy Arnold Sihite, Erwan Martanto, et al. (+2)
12 [GO] 2021―Feb―19 Amantadine in the prevention of clinical symptoms caused by SARS-CoV-2 Albert Cortés-Borra, Gonzalo Emiliano Aranda-Abreu
13 [GO] 2021―Jan―03 Ivermectin as a potential drug for treatment of COVID-19: an in-sync review with clinical and computational attributes Harpinder Kaur, Nishant Shekhar, Saurabh Sharma, Phulen Sarma, Ajay Prakash, Bikash Medhi
14 [GO] 2021―Jan―03 SARS-CoV-2 therapeutics: how far do we stand from a remedy? Anurag Singh, Vandana Gupta
15 [GO] 2020―Nov―09 The effect of tocilizumab on cytokine release syndrome in COVID-19 patients Carmen de Cáceres, Rodrigo Martínez, Pablo Bachiller, Laura Marín, José Manuel García
16 [GO] 2020―Oct―28 Overview of the possible role of vitamin C in management of COVID-19 Anis Abobaker, Aboubaker Alzwi, Alsalheen Hamed A. Alraied
17 [GO] 2020―Oct―15 Ciprofloxacin and moxifloxacin could interact with SARS-CoV-2 protease: preliminary in silico analysis Krzysztof Marciniec, Artur Beberok, Paweł Pęcak, Stanisław Boryczka, Dorota Wrześniok
18 [GO] 2020―Oct―10 Observational study of people infected with SARS-Cov-2, treated with amantadine Gonzalo Emiliano Aranda-Abreu, José D. Aranda-Martínez, Ramiro Araújo, María Elena Hernández-Aguilar, Deissy Herrera-Covarrubias, Fausto Rojas-Durán
19 [GO] 2020―Sep―05 Drug repurposing approach to fight COVID-19 Thakur Uttam Singh, Subhashree Parida, Madhu Cholenahalli Lingaraju, Manickam Kesavan, Dinesh Kumar, Raj Kumar Singh
20 [GO] 2020―Aug―20 Pharmacological treatments of COVID-19 Adeleh Sahebnasagh, Razieh Avan, Fatemeh Saghafi, Mojataba Mojtahedzadeh, Afsaneh Sadremomtaz, Omid Arasteh, et al. (+8)
21 [GO] 2020―Jul―22 Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19 Moshe Rogosnitzky, Paul Okediji, Igor Koman


[de][en]

Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.017 sec